Search

Ionis Pharmaceuticals Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

54.46 -0.35

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

53.4

Max

54.61

Pagrindiniai rodikliai

By Trading Economics

Pajamos

136M

-93M

Pardavimai

43M

246M

Pelnas, tenkantis vienai akcijai

-0.3

Pelno marža

-37.599

Darbuotojai

1,402

EBITDA

-4.7B

-69M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+73.03% upside

Dividendai

By Acuity

Kitas uždarbis

2026-07-29

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-2.3B

9.6B

Ankstesnė atidarymo kaina

54.81

Ankstesnė uždarymo kaina

54.46

Naujienos nuotaikos

By Acuity

50%

50%

155 / 340 reitingas Healthcare

Ionis Pharmaceuticals Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-07-17 23:56; UTC

News
Social Media

Micron Technology shares are lower in after-market trading amid a decline in India's smartphone shipments and ongoing memory cost pressures affecting margins.

2026-07-17 23:36; UTC

News

GameStop increased its stake in eBay to nearly 10%, acquiring 3.5 million shares for about $381 million. eBay shares are gaining in after-market trading.

2026-07-17 23:36; UTC

Macro News
News
ETF Constituents

Vanguard Information Technology ETF rises slightly in after-market trading, supported by gains in Microsoft, Analog Devices, Adobe, Qualcomm, and Snowflake.

2026-07-17 23:21; UTC

Social Media
News
Correlated Moves

Meta Platforms Inc. shares declined in after-market trading amid concerns over $125 billion to $145 billion in projected AI spending and slower development timelines.

2026-07-17 23:16; UTC

News

United Airlines reported record Q2 revenue of $17.7 billion, a 16% increase. Shares were little changed during after-market hours following the announcement.

2026-07-17 23:16; UTC

News
Social Media

PayPal Holdings Inc shares are lower in after-market trading amid reports of a potential bid, though analysts remain cautious about growth prospects.

2026-07-17 23:16; UTC

News
ETF Constituents
Macro News
Correlated Moves

GDX trades higher in after-market hours, supported by positive analysis and strong performance expectations amid rising geopolitical tensions and crude oil prices.

2026-07-17 23:06; UTC

News

Baidu Inc. partners with Apple to enhance its AI capabilities and pursues a dual-primary listing in Hong Kong, shares higher in after-market trading.

2026-07-17 23:06; UTC

ETF Constituents
News

Vanguard Growth ETF trades lower in after-market hours, continuing a downward trend. Top holdings META, AMAT, and LLY negatively impacted performance.

2026-07-17 20:07; UTC

News
Social Media

European Union approval is anticipated for the $55 billion acquisition of Electronic Arts by a group of investors, including Saudi Arabia's Public Investment Fund.

2026-07-17 20:07; UTC

News
Social Media

Tesla Inc shares are lower as investors await the earnings report on July 22. Concerns over Semi truck rollout and autonomous driving goals weigh on sentiment.

2026-07-17 20:07; UTC

Macro Event
Social Media
Correlated Moves
News

Broadcom shares declined to around $371.69 today, amid increased bearish sentiment and concerns over potential breakdowns below key support levels.

2026-07-17 20:07; UTC

News

Ethereum is trading lower as geopolitical tensions and rising oil prices heighten inflation concerns. Ongoing worries about tech valuations also impact its performance.

2026-07-17 20:07; UTC

News

Bitcoin is rising during Friday's session amid geopolitical tensions and rising oil prices, though it has pulled back from earlier session highs.

2026-07-17 20:07; UTC

News
Macro Event

Geopolitical tensions and rising oil prices support Bitcoin's gains during Friday's session, despite earlier pullbacks and regulatory scrutiny from former President Trump.

2026-07-17 20:03; UTC

News

J B Hunt shares are lower as freight shipments decline and inflationary pressures persist. The Cass Freight Index reported a 4.1% year-over-year drop in June.

2026-07-17 20:03; UTC

News
Social Media
Correlated Moves

Western Digital Corp shares are higher, supported by projected revenue growth of 43.7% and improved operating margins, despite earlier volatility and a pullback from session highs.

2026-07-17 20:03; UTC

News
Macro Event

Ulta Beauty is gaining as Evercore highlights its innovation amid positive consumer sentiment data, despite an earlier pullback from session highs.

2026-07-17 20:03; UTC

Correlated Moves
News
Social Media

Alphabet Inc. shares are declining amid reports of delays in the Gemini project rollout, overshadowing BMO's price target increase to $455.

2026-07-17 20:03; UTC

News
Correlated Moves
Social Media

Alphabet Inc shares are lower amid a securities fraud investigation and delays in its AI model rollout. BMO raised its price target to $455.

2026-07-17 20:02; UTC

News

Wynn Resorts Ltd is lower amid broader market declines and a negative outlook from StockStory, citing financial challenges and modest sales growth.

2026-07-17 20:01; UTC

News

NetApp Inc. shares are higher as StockStory highlights a $177.25 price target and strong growth in billings and earnings per share.

2026-07-17 19:56; UTC

News

Gilead Sciences shares are lower as the company missed full-year EPS estimates despite reporting $6.96 billion in revenue, reflecting heightened market volatility.

2026-07-17 19:56; UTC

News
Social Media

Apple Inc. is in early settlement discussions regarding an antitrust lawsuit. The company regained its status as the world's most valuable, surpassing Nvidia.

2026-07-17 19:52; UTC

News
Social Media
Correlated Moves

NVIDIA shares are declining amid a broader semiconductor sell-off and competitive concerns from Moonshot AI's new model. Apple has surpassed NVIDIA in market value.

2026-07-17 19:52; UTC

News
Correlated Moves

NXP Semiconductors NV is trading lower amid a broader market decline and rising pressures in the semiconductor industry, impacting its valuation narrative.

2026-07-17 19:52; UTC

News
Social Media
Correlated Moves

AMD declines today amid broader market losses, pulling back from session high.

2026-07-17 19:46; UTC

Social Media
News
Macro Event

Shares of American Airlines are lower today, trading around $15.03 amid increased bearish sentiment reflected in a rising put/call ratio of 1.61.

2026-07-17 19:46; UTC

Social Media
Correlated Moves
News

CSX shares are lower as Daniel Loeb exits his 500,000-share position, following significant cuts in other railroad investments amid regulatory scrutiny.

2026-07-17 19:46; UTC

News
Macro Event

Autodesk announces a collaboration with Amazon Web Services and raises revenue guidance to $8.5 billion, as shares gain during Friday's session.

Akcijų palyginimas

Kainos pokytis

Ionis Pharmaceuticals Inc Prognozė

Kainos tikslas

By TipRanks

73.03% į viršų

12 mėnesių prognozė

Vidutinis 94.11 USD  73.03%

Aukščiausias 125 USD

Žemiausias 68 USD

Remiantis 20 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Ionis Pharmaceuticals Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

20 ratings

17

Pirkti

3

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

155 / 340 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an antisense injection for the treatment of polyneuropathy caused by hereditary transthyretin amyloidosis in adults; and WAYLIVRA, an antisense medicine for treatment for familial chylomicronemia syndrome (FCS) and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to treat all types of ATTR; Olezarsen for patients with FCS and severe hypertriglyceridemia (SHTG); Donidalorsen for patients with hereditary angioedema; ION363 for patients with amyotrophic lateral sclerosis; Tofersen to inhibit the production of superoxide dismutase 1; Pelacarsen for patients with established cardiovascular disease and elevated lipoprotein(a); and Bepirovirsen to inhibit the production of viral proteins associated with hepatitis B virus. In addition, the company develops IONIS-FB-LRx to inhibit the production of complement factor B and the alternative complement pathway; and ION224 to reduce the production of diacylglycerol acyltransferase 2. It has a strategic collaboration with Biogen for the treatment of neurological disorders; and collaboration and license agreement with Metagenomi, Inc, AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis, Roche, Swedish Orphan Biovitrum AB, and PTC Therapeutics. The company was incorporated in 1989 and is based in Carlsbad, California.
help-icon Live chat